Revelstoke Capital Partners closed its sale of Accelecare Wound Centers Inc. to Healogics Inc., which is backed by Clayton Dubilier & Rice. Financial terms weren’t announced. Bellevue, Washington-based Accelecare is a wound care and disease management company. RBC Capital Markets advised Accelecare.
DENVER–(BUSINESS WIRE)–Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, has completed the sale of Accelecare Wound Centers, Inc. (“Accelecare” or the “Company”) to Healogics, Inc. (“Healogics”).
Accelecare and Healogics are two of the leading providers of advanced wound care services throughout the United States. Accelecare provides advanced wound care services in two diversified, highly complementary divisions, Accelecare Wound Centers, which offers full service wound management solutions to hospitals and related healthcare organizations, and Accelecare Wound Professionals, which provides wound care specialist physicians to skilled nursing facilities and hospital-based outpatient wound care facilities.
“We are very pleased with the pace of Accelecare’s growth since we completed our investment in December 2013. Management’s intense focus on expanding the Company’s footprint while increasing operational efficiencies created an attractive asset in the growing wound care market,” noted Mark King, CEO, Managing Partner and Co-Founder of Revelstoke.
“We appreciate Revelstoke’s strategic guidance and support in our rapid growth, and we look forward to a great future with Healogics,” commented Michael Lester, Chairman and CEO of Accelecare.
“Accelecare has an exceptional market position and brand reputation in the wound care industry. We see incredible value in this acquisition, through which the combined business will benefit from increased operational scale enabling us to reach and heal more patients with chronic wounds,” said Jeff Nelson, CEO of Healogics.
Accelecare was represented by RBC Capital Markets and Fenwick and West LLP. Debevoise and Plimpton LLP represented Healogics in the transaction.
Based in Bellevue, Washington, Accelecare Wound Centers is a comprehensive wound care and disease management company. Accelecare provides full service wound management solutions to hospitals and related health care organizations across the United States. Accelecare is currently comprised of nearly 140 state of the art Advanced Wound Centers staffed with trained physicians, nurses, and specialized technicians that provide efficacious and cost effective wound treatments ensuring positive outcomes. The Company’s mission is centered on partnerships with hospitals and skilled nursing facilities, caring services for patients, and clinical excellence.
Headquartered in Jacksonville, FL., Healogics is the nation’s largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 600 Wound Care Centers® in the nation and saw more than 234,000 patients in 2014 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post-acute sites. Healogics utilizes an evidence-based systematic approach to chronic wound healing to treat an underserved and growing patient population. A fund managed by Clayton, Dubilier & Rice, a private investment firm, is the majority shareholder of Healogics. For more information, please visit www.healogics.com.
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Revelstoke’s Managing Partners, Mark King, Dale Meyer and Simon Bachleda, have completed over 100 platform and add-on acquisitions, representing over $5 billion of total enterprise value.